The Canadian Veterinary Journal La Revue Vétérinaire Canadienne Imaging and Clinical Features of a True Gastrogastric Intussusception in a Dog
Total Page:16
File Type:pdf, Size:1020Kb
July/Juillet 2020 July/Juillet The Canadian Veterinary Journal Vol. 61, No. 07 Vol. La Revue vétérinaire canadienne July/Juillet 2020 Volume 61, No. 07 The Canadian Veterinary Journal Canadian Veterinary The Imaging and clinical features of a true gastrogastric intussusception in a dog The outcome for feline non-hypersecretory thyroid carcinoma after thyroidectomy Septic fibrinous pericarditis in 4 horses in Saskatchewan following an outbreak of forest tent caterpillars in 2017 Acute hyperkalemia as anesthetic La Revue vétérinaire canadienneLa Revue vétérinaire complication in a diabetic dog undergoing tumor excision Glucagon therapy in canines with an insulinoma: A retrospective descriptive study of 11 dogs Evaluation of 1,2-o-dilauryl-rac-glycero- 3-glutaric acid-(69-methylresorufin) ester lipase concentrations in cats with kidney disease and with normal SNAP fPL Evaluation of radiographs for the detection of sublumbar lymphadenopathy in dogs Gap between producers and veterinarians regarding biosecurity on Quebec dairy farms Descriptive epidemiology of companion animal dermatophytosis in a Canadian Pacific Northwest animal shelter system Isolation of Histophilus somni and Trueperella pyogenes from a 2-month-old calf with chronic fibrosing and suppurative epididymitis FOR PERSONAL USE ONLY THANK YOU! CLAVASEPTIN PETS ARE GRATEFUL FOR 10 AMAZING YEARS OF LOVE AND CARE 10 YEARS OF Ease of administration Treatment compliance and success Giving back to pets and partners 2010 2012 2016 2017 2020 CLAVASEPTIN PAWS FOR GOAT PASS-ON CANADA-NORTH 10-YEAR LAUNCH THOUGHT PROJECT PROJECT PROJECT CELEBRATION www.vetoquinol.ca FOR PERSONAL USE ONLY Canada’s Most Trusted Insurance Program A Specialized Insurance Program for the Canadian Veterinarian Industry Professional Liability | Commercial Insurance | Employee Benefits Join now and receive preferred member pricing on Commercial Insurance and Employee Benefits! Available exclusively to members of the Canadian Veterinary Medical Association. The CVMA Insurance Program offers the most comprehensive and cost-effective insurance protection for you, your employees and your practice. 1-866-860-2862 cvmainsurance.com FOR PERSONAL USE ONLY Keep your clients coming back, for life IDEXX Preventive Care Everything you need to implement diagnostics, for a lifetime of healthy relationships IDEXX Preventive Care profiles Tools to get clients to yes Dedicated IDEXX team for implementation Discover more at idexx.ca/PreventiveCare © 2020 IDEXX Laboratories, Inc. All rights reserved. • 2220140-00 All ®/TM marks are owned by IDEXX Laboratories, Inc. or its affiliates in the United States and/or other countries. The IDEXX Privacy Policy is available at idexx.ca. FOR PERSONAL USE ONLY JULY/JUILLET 2020 Contents Table des matières SCIENTIFIC RUBRIQUE SCIENTIFIQUE CASE REPORTS ARTICLES RAPPORTS DE CAS 743 Evaluation of 1,2-o-dilauryl-rac-glycero-3- 715 Imaging and clinical features of a true glutaric acid-(69-methylresorufin) ester gastrogastric intussusception in a dog lipase concentrations in cats with kidney Lindsey T. Graham, Mylène Auger, disease and with normal SNAP fPL Allison M. Watson, Christian Folk, Anne-Sophie Bua, Carolyn Grimes, Adrien-Maxence Hespel Guy Beauchamp, Marilyn E. Dunn 719 The outcome for feline non-hypersecretory 749 Evaluation of radiographs for the detection thyroid carcinoma after thyroidectomy of sublumbar lymphadenopathy in dogs Alberto Oramas, Sarah Boston, Vincent Wavreille Megan C. Murphy, Martin Sullivan, Barbara J. Gomes, Ada Kaczmarska, 724 Septic fibrinous pericarditis in 4 horses Gawain J.C. Hammond in Saskatchewan following an outbreak of forest tent caterpillars in 2017 757 Gap between producers and veterinarians Ronan J.J. Chapuis, Valentina M. Ragno, regarding biosecurity on Quebec dairy farms Cristian A. Ariza, Ahmad R. Movasseghi, José Denis-Robichaud, David F. Kelton, Soraya Sayi, Fabienne D. Uehlinger, Cathy A. Bauman, Herman W. Barkema, Julia B. Montgomery Gregory P. Keefe, Jocelyn Dubuc 731 Acute hyperkalemia as anesthetic 763 Descriptive epidemiology of companion complication in a diabetic dog undergoing animal dermatophytosis in a Canadian tumor excision Pacific Northwest animal shelter system Chiara Hampton, Jon Fletcher, Mika Fitzgerald, Emilia Gordon, Amanda Idle, Lena DeTar R. Avery Bennett STUDENT PAPER 737 Glucagon therapy in canines with an COMMUNICATION ÉTUDIANTE insulinoma: A retrospective descriptive study of 11 dogs 776 Isolation of Histophilus somni and Megan E. Harris, Linda Weatherton, Trueperella pyogenes from a 2-month-old Christopher P. Bloch calf with chronic fibrosing and suppurative epididymitis Rachel Dobberstein 679 QUIZ CORNER TEST ÉCLAIR CVJ / VOL 61 / JULY 2020 667 FOR PERSONAL USE ONLY And add more games of fetch to the to-do list. New Galliprant™ (grapiprant tablets) is a first-in-class prostaglandin receptor antagonist (PRA) that treats pain and inflammation while reducing the impact on GI, kidney and liver homoeostasis.1–3 Instead of inhibiting COX enzymes, Galliprant acts on the EP4 receptor,*1,2 providing effective relief for canine patients as young as 9 months of age and over 3.6 kg in weight. For more fetches, prescribe Galliprant from the first diagnosed stages of canine osteoarthritis. FOR MORE INFORMATION *Grapiprant is a non-steroidal, non-cyclooxygenase inhibiting anti-inflammatory drug in the piprant class. Grapiprant is a selective antagonist of the EP4 receptor. ABOUT GALLIPRANT, INDICATION FOR USE CONTACT YOUR ELANCO Galliprant is indicated for the treatment and control of pain and inflammation associated with osteoarthritis in dogs.1 SALES REPRESENTATIVE. IMPORTANT SAFETY INFORMATION The label contains complete use information, including cautions, and warnings. Always read, understand and follow the label. REFERENCES 1. Galliprant Canadian product label. 2. Kirkby Shaw K, Rausch-Derra L, Rhodes L. Grapiprant: an EP4 prostaglandin receptor antagonist and novel therapy for pain and inflammation. Vet Med Sci. 2015;2:3-9. 3. Rausch-Derra L, Huebner M, Wofford J, et al. A prospective, randomized, masked, placebo-controlled multi-site clinical study of grapiprant, an EP4 prostaglandin receptor antagonist (PRA), in dogs with osteoarthritis. J Vet Intern Med. 2016;30(3):756-763. Galliprant, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. © 2019 Elanco or its affiliates. PM-CA-19-0220 FOR PERSONAL USE ONLY JULY/JUILLET 2020 Contents Table des matières FEATURES RUBRIQUES PRESIDENT’S MESSAGE 789 DIAGNOSTIC OPHTHALMOLOGY LE MOT DE LA PRÉSIDENTE OPHTALMOLOGIE DIAGNOSTIQUE 673 Navigating through COVID-19 Shayna Levitt, Stephanie Osinchuk, Composer avec la COVID-19 Lynne Sandmeyer Melanie Hicks BOOK REVIEWS 677 VETERINARY MEDICAL ETHICS COMPTE RENDU DE LIVRES DÉONTOLOGIE VÉTÉRINAIRE 742 That sheep may safely graze: Rebuilding animal health care in war-torn Afghanistan 689 2019 CVMA ANNUAL REPORT Barry Stemshorn RAPPORT ANNUEL 2019 DE L’ACMV 775 Language Signs & Calming Signals of Horses: Recognition and Application VETERINARY WELLNESS Kristine Torske BIEN-ÊTRE VÉTÉRINAIRE 771 Managing change in a changing world NOTICES ANNONCES Part 2: The power to choose Debbie L. Stoewen 774 Industry News Nouvelles de l’industrie VETERINARY DERMATOLOGY DERMATOLOGIE VÉTÉRINAIRE 791 Index of Advertisers 781 Twenty years of pyodermas: How Index des annonceurs antimicrobial resistance has changed 792 Classifieds the way I practice Petites annonces Kinga Gortel VETERINARY PRACTICE MANAGEMENT NEWS | NOUVELLES GESTION D’UNE CLINIQUE VÉTÉRINAIRE 785 Surviving a downturn: How to keep 681 NEWS your practice afloat/Survivre à un NOUVELLES ralentissement : comment maintenir votre pratique à flot Heather Broughton, Sophie Perreault Chris Doherty Contributors “Instructions for authors” are available online (www.canadianveterinarians.net). Les «Directives à l’intention des auteurs» sont disponibles en ligne (www.veterinairesaucanada.net). CVJ / VOL 61 / JULY 2020 669 FOR PERSONAL USE ONLY The Canadian Veterinary Journal Editorial policy: All published articles including editorials and letters reflect the La Revue vétérinaire canadienne opinions of the authors and do not necessarily reflect the opinion of the publisher. Publication of an advertisement does not necessarily imply that the publisher agrees 339 rue Booth Street with or supports the claims therein. Ottawa, Ontario K1R 7K1 The Canadian Veterinary Medical Association holds complete copyright of all articles Telephone: 613-236-1162 within this issue. Fax: 613-236-9681 Politique de la Rédaction : Tous les articles publiés, y compris les éditoriaux et les E-mail: [email protected] lettres, représentent l’opinion de l’auteur et non pas nécessairement la position de Website/Site Web: www.canadianveterinarians.net l’éditeur. www.veterinairesaucanada.net La publication d’une annonce ne signifie pas nécessairement que l’éditeur est d’accord avec son contenu ou qu’il l’appuie. © C anadian Veterinary Medical Association 2020 L’Association canadienne des médecins vétérinaires détient le droit d’auteur complet L’Association canadienne des médecins vétérinaires 2020 sur tous les articles contenus dans le présent numéro. The Canadian Veterinary Journal is indexed or abstracted in: Editor-in-Chief/Rédacteur en chef La Revue vétérinaire canadienne est indexée ou ses articles sont Dr. Carlton Gyles, Guelph, Ontario résumés dans : AGRICOL, Biological Abstracts, Capsule Report, Current Contents — Agriculture, Associate Editors/Rédacteurs associés Derwent Veterinary Drug File,